3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Myelodysplastic Syndromes
5
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Leukemia, Myelomonocytic, Chronic
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
GATA2 Deficiency
2
Anemia, Refractory, with Excess of Blasts
2
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Neoplasm Metastasis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
12
Gemcitabine
9
Specimen Handling
6
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
Drug Therapy
5
toripalimab
4
Platinum
4
Nivolumab
4
Capecitabine
4
1,2-diaminocyclohexaneplatinum II citrate
4
spartalizumab
3
Radiotherapy
3
Immune Checkpoint Inhibitors
3
sintilimab
2
Ipilimumab
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
tislelizumab
1
relatlimab
1
pembrolizumab
1
olaparib
1
fluciclovine F-18
1
dehydroftorafur
1
cemiplimab
1
camrelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Azacitidine
×
30 days
×
Clear all
No trials found.